Products for Research Use Only
RegisterLogin

Imatinib mesylate

CAT: 0013-GTR19175335-02Size: 100 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19175335-02Size:100 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Imatinib Mesylate is an orally active, multi-targeted tyrosine kinase inhibitor that potently suppresses BCR-ABL, PDGFR, and c-Kit. It is a foundational research tool for studying oncogenic signaling and has demonstrated efficacy in both in vitro assays and in vivo models of chronic myeloid leukemia and other cancers.
CAS Number
220127-57-1
Product Name Alternative
Gleevec; STI571
Field of Research
Cell Biology
Purity
>98%
Bioactivity
BCR-ABL inhibitor
Form
Powder
Solubility
Soluble in DMSO (up to 50 mg/ml) or in Water (up to 50 mg/ml) .
Smiles
CS (O) (=O) =O.CN1CCN (Cc2ccc (cc2) C (=O) Nc2ccc (C) c (Nc3nccc (n3) -c3cccnc3) c2) CC1
Molecular Formula
C29H31N7O ∙ CH3SO3H
Molecular Weight
493.62 ∙ 96.11
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
4-[ (4-Methyl-1-piperazinyl) methyl]-N-[4-methyl-3-[[4- (3-pyridinyl) -2-pyrimidinyl]amino]phenyl]benzamide methanesulfonate

Chemical Information

Imatinib Mesylate

Imatinib methanesulfonate is a methanesulfonate (mesylate) salt that is the monomesylate salt of imatinib. Used for treatment of chronic myelogenous leukemia and gastrointestinal stromal tumours. It has a role as an anticoronaviral agent, an antineoplastic agent, a tyrosine kinase inhibitor and an apoptosis inducer. It contains an imatinib.

CAS Number220127-57-1
PubChem CID123596
IUPAC Namemethanesulfonic acid;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide
Molecular FormulaC30H35N7O4S
Molecular Weight589.7
Topological Polar Surface Area149
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count10
Rotatable Bond Count7
Heavy Atom Count42
Formal Charge0
Complexity799
SMILES
CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O
InChI
InChI=1S/C29H31N7O.CH4O3S/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36;1-5(2,3)4/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34);1H3,(H,2,3,4)
InChIKey
YLMAHDNUQAMNNX-UHFFFAOYSA-N
Chemical Structure
2D Structure
2D structure of Imatinib Mesylate
CAS: 220127-57-1
CID: 123596
Formula: C30H35N7O4S
MW: 589.7
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight589.7
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count10
Rotatable Bond Count7
Exact Mass589.24712380
Monoisotopic Mass589.24712380
Topological Polar Surface Area149 Ų
Heavy Atom Count42
Formal Charge0
Complexity799
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count2
Compound Is CanonicalizedYes

Related Products

CatalogName
GTR19217391-01Imatinib
GTR19172052-01Imatinib
GTR19225055-01Imatinib carbaldehyde
GTR19320346-01Imatinib Acid
GTR19201234-01Imatinib hydrochloride
GTR19184239-01Imatinib impurities3
GTR19243753-01Imatinib impurities3
GTR19280939-01Imatinib impurity 12
GTR19222090-01Imatinib Impurity E
GTR19216941-01N-Desmethyl imatinib

Alternative Products

CatalogName
RM-I132080-01Imatinib Mesylate
ALX-270-492-M025Imatinib . mesylate
HY-50946-01Imatinib (Mesylate)

Popular Products